+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


GMP Testing Service Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • ID: 5318194
  • Report
  • February 2022
  • Region: Global
  • 121 Pages
  • Mordor Intelligence


  • Almac Group
  • Eurofins Scientific
  • Intertek Group Plc
  • Microchem Laboratory
  • Pace Analytical
  • PPD Inc.

The GMP testing service market was valued at USD 1,161.23 million in 2021 and expected to register a CAGR of 6.97% during the forecast period owing to the growing pharmaceutical industry and the increasing need for developing novel devices and drugs.

After the outbreak of respiratory disease caused by a novel coronavirus in January 2020, quick lockdowns and shutdowns have been imposed to control the spread of the virus causing Covid-19. These lockdowns and shutdowns have shown both demand-side and supply-side impacts on the manufacturing sector. But as people learned to live with the new normal and all industries have opened with new guidelines and new restrictions, in 2021 the market has seen a growth than the previous year. According to European Commission, Eurostat 2021, Industrial production in Europe increased by 1.4% in July 2021 and the total production level was 1% above the level of February 2020, the month just before the Covid-19 crisis. And according to Eurostat 2021, the production of pharmaceutical products and goods increased by more than 30% between July 2020 and July 2021.

According to the European Federation of Pharmaceutical Industries and Associations, the pharmaceutical market sales worldwide was estimated to be USD 1,077,856 million in 2020. Furthermore, according to the International Journal of Environmental Research and Public Health’s published study, in the United States and South Korea around 40 medications are recalled per year. This enhances the need for testing the products and the manufacturing process. The outsourcing of these services enables companies to reduce capital investments as well.

While the above factors are expected to play a major role in the GMP testing services market growth. However, the precise requirement of the regulatory framework concerning GMP outsourced activities may hinder the market growth in the studied forecast period.

Key Market Trends

Pharmaceutical and Biopharmaceutical Companies Segment is Expected to Hold a Major Market Share in the GMP Testing Service Market

The pharmaceutical and biopharmaceutical companies segment is expected to grow during the forecast period.

The novel drug development in the pharmaceutical and biopharmaceutical industry is expected to drive market growth in this segment. According to an article entitled “Current perspectives on biosimilars” published in the Journal of Industrial Microbiology & Biotechnology in July 2019, almost 300 biopharmaceuticals have been patented in the last three decades. International Federation of Pharmaceutical Manufacturers and Associations, “Facts & Figures Report 2021”, as of February 2021, approximately 382 vaccine candidates were in development, among which 24 were in Phase I, 34 were in Phase II and 23 were in Phase III trial. According to the same report, as of March 2021, the United States Food and Drug Administration (FDA) has authorized PfizerBioNTech, Janssen, and Moderna COVID-19 vaccines, among which European Medicines Agency (EMA) granted a conditional marketing authorization Pfizer-BioNTech, Janssen, Moderna, and AstraZeneca’s COVID-19 vaccines.

The biopharmaceutical industry is undertaking rapid and exceptional measures to bring vaccines to patients and the biopharmaceutical sector has opened new approaches and collaborations in the industry to respond to the urgent needs of the pandemic. But this demands more quality and safety management of products, which is expected to increase GMP testing services. Therefore, the pharmaceutical and biopharmaceutical companies segment is propelling the growth of the market and expected to positively impact the GMP testing services market growth during the forecast period as well.

North America is Expected to Hold a Significant Share in the Market and is Expected to do Same in the Forecast Period.

North America is expected to be a dominant region in the GMP testing services market due to the emerging need for developing new drugs and devices.

According to the Centre for Disease Control and Prevention data reviewed on 10 January 2022, more than 868,000 Americans die of heart disease, or stroke, almost 600,000 dies from Cancer in the United States, every year, and more than 34.2 million Americans have diabetes. Due to these incidences of deaths and increasing number of chronic diseases, the number of increasing drug manufacturing plants is growing and is expected to drive the GMP testing services market growth.

According to the United States Food & Drug Administration (FDA), in 2019 the United States had approximately 4,676 manufacturing sites for drugs and many others are in standby. Considering these factors, the demand for developing new drugs and pharmaceuticals is increasing which is contributing to propel the demand for GMP testing services market growth in the forecast period and furthermore.

Competitive Landscape

The GMP testing service market consists of several major players. In terms of market share, few of the major players are currently dominating the market. Furthermore, the companies are taking initiatives to meet the higher demand for medicines and devices. Some of the companies which are currently dominating the market are Eurofins Scientific, PPD, Inc., Microchem Laboratory, Sartorius AG, North American Science Associates Inc., Covance, Inc., Nelson Laboratories, LLC, Almac Group, Pace Analytical, Wuxi AppTec., Intertek Group Plc, Charles River Laboratories.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Note: Product cover images may vary from those shown


  • Almac Group
  • Eurofins Scientific
  • Intertek Group Plc
  • Microchem Laboratory
  • Pace Analytical
  • PPD Inc.

1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Pharmaceutical Industry
4.2.2 Increasing Drug and Devices Development
4.3 Market Restraints
4.3.1 Stringent Regulatory Framework
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Service Type
5.1.1 Product Validation Testing
5.1.2 Bioanalytical Services
5.1.3 Packaging and Shelf-Life Testing
5.1.4 Other Service Types
5.2 By End User
5.2.1 Pharmaceutical and Biopharmaceutical Companies
5.2.2 Medical Devices Company
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Rest of the World
6.1 Company Profiles
6.1.1 Eurofins Scientific
6.1.2 PPD Inc.
6.1.3 Microchem Laboratory
6.1.4 Sartorius AG
6.1.5 North American Science Associates Inc.
6.1.6 Laboratory Corporation of America Holdings (Covance Inc.)
6.1.7 Sotera Health (Nelson Laboratories LLC)
6.1.8 Almac Group
6.1.9 Pace Analytical
6.1.10 Wuxi AppTec
6.1.11 Intertek Group Plc
6.1.12 Charles River Laboratories
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Eurofins Scientific
  • PPD Inc.
  • Microchem Laboratory
  • Sartorius AG
  • North American Science Associates Inc.
  • Laboratory Corporation of America Holdings (Covance Inc.)
  • Sotera Health (Nelson Laboratories LLC)
  • Almac Group
  • Pace Analytical
  • Wuxi AppTec
  • Intertek Group Plc
  • Charles River Laboratories
Note: Product cover images may vary from those shown